FIELD : medicine.SUBSTANCE : invention relates to the field of medicine, namely to ophthalmology, and is intended for the treatment of inflammatory, viral, bacterial, allergic, metabolic, traumatic diseases. Eye drops consist of interferon, antihistamine, sodium hyaluronate, taurine, cyanocobalamin or hydroxocobalamin, sodium phosphate monobasic, boric acid, disodium edetate and water. Antihistamine is selected from the group : olopatadine, azelastine or levocabastine. Components are used in claimed amounts.EFFECT : use of the invention provides complex therapy that exerts anti-inflammatory, antiviral, antiallergic, antimetabolite and regenerative effects.1 cl, 1 tbl, 12 ex